Tissue Science Evolved
Advanced Biologics' (ABC) focus is to develop innovative and clinically relevant biologic solutions across a wide degree of medical specialties. Our company is fully dedicated to improving patients' lives and the health care provider's experience with our products.
The OsteoAMP® family of osteoinductive/conductive products was the first line of orthobiologic offerings produced by ABC and was acquired by Bioventus in 2014.
Current technology platform(s) include a cellular bone matrix, OsseoGEN®, and an allograft-derived growth factor, ProteiOS®. The company was formed in 2009 and is headquartered in southern California.